Section 1 Short title
This Act may be cited as the “Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act” or the “STOP Fentanyl and Xylazine Act”.
Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act
A BILL
To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.
Sec. 2 Clarification regarding the treatment of equipment that indicates the presence of fentanyl or xylazine in a compound
Section 422 of the Controlled Substances Act (21 U.S.C. 863) is amended by adding at the end the following:
“(g) Clarification—This section does not apply to the possession, sale, purchase, importation, exportation, or transportation of equipment for which the intended use is to indicate the presence of fentanyl or xylazine in a compound.”